Kim, Si Hyoung <br/><br/>
The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells.  [electronic resource] 

 -  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine  Oct 2017 
 - 1010428317722068 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1423-0380 
<br/><br/><label>Standard No.: </label>10.1177/1010428317722068  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Carcinoma--pathology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Dipeptidyl-Peptidase IV Inhibitors--pharmacology<br/>Drug Synergism<br/>Flow Cytometry<br/>Humans<br/>Isoxazoles--pharmacology<br/>Piperidones--pharmacology<br/>Pyrimidines--pharmacology<br/>Resorcinols--pharmacology<br/>Signal Transduction--drug effects<br/>Thyroid Neoplasms--pathology